Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Clifford

Showing results (271-280 of 347) with videos related to

Pageof 35
Sort By:
Journal of Neuro-Oncology|September 4, 2003
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapyHideho Okada, Frank S Lieberman, Howard D Edington, et al.
Health Technology Assessment (Winchester, England)|November 4, 2009
Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative studyI C K Wong, P Asherson, A Bilbow, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expressionJulie G Izzo, Usha Malhotra, Tsung-Teh Wu, et al.
Cancer|November 25, 2003
Management of nonsinonasal neuroendocrine carcinomas of the head and neckJerry L Barker, Bonnie S Glisson, Adam S Garden, et al.
Cancer|October 30, 2007
Outcomes after radiotherapy for squamous cell carcinoma of the eyelidJanjira Petsuksiri, Steven J Frank, Adam S Garden, et al.
Head & Neck|January 31, 2012
Expression of hedgehog signaling molecules as a prognostic indicator of oral squamous cell carcinomaYi-Fen Wang, Chun-Ju Chang, Chin-Ping Lin, et al.
Investigational New Drugs|October 31, 2003
A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors consortium reportSusan M Chang, John G Kuhn, H Ian Robins, et al.
Cancer Immunology, Immunotherapy : CII|December 23, 2017
Cytosolic high-mobility group box protein 1 (HMGB1) and/or PD-1+ TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapyChih-Yang Huang, Shu-Fen Chiang, Tao-Wei Ke, et al.
Neuro-Oncology|April 4, 2003
A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant gliomaMichael D Prados, S Clifford Schold, Howard A Fine, et al.
Current Oncology Reports|February 19, 2005
Intensity-modulated radiotherapy: is xerostomia still prevalent?Mark S Chambers, Adam S Garden, David Rosenthal, et al.
Pageof 35

Showing results (271-280 of 347) with videos related to

Sort By:
Pageof 35
Journal of Neuro-Oncology|September 4, 2003
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapyHideho Okada, Frank S Lieberman, Howard D Edington, et al.
Health Technology Assessment (Winchester, England)|November 4, 2009
Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative studyI C K Wong, P Asherson, A Bilbow, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expressionJulie G Izzo, Usha Malhotra, Tsung-Teh Wu, et al.
Cancer|November 25, 2003
Management of nonsinonasal neuroendocrine carcinomas of the head and neckJerry L Barker, Bonnie S Glisson, Adam S Garden, et al.
Cancer|October 30, 2007
Outcomes after radiotherapy for squamous cell carcinoma of the eyelidJanjira Petsuksiri, Steven J Frank, Adam S Garden, et al.
Head & Neck|January 31, 2012
Expression of hedgehog signaling molecules as a prognostic indicator of oral squamous cell carcinomaYi-Fen Wang, Chun-Ju Chang, Chin-Ping Lin, et al.
Investigational New Drugs|October 31, 2003
A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors consortium reportSusan M Chang, John G Kuhn, H Ian Robins, et al.
Cancer Immunology, Immunotherapy : CII|December 23, 2017
Cytosolic high-mobility group box protein 1 (HMGB1) and/or PD-1+ TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapyChih-Yang Huang, Shu-Fen Chiang, Tao-Wei Ke, et al.
Neuro-Oncology|April 4, 2003
A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant gliomaMichael D Prados, S Clifford Schold, Howard A Fine, et al.
Current Oncology Reports|February 19, 2005
Intensity-modulated radiotherapy: is xerostomia still prevalent?Mark S Chambers, Adam S Garden, David Rosenthal, et al.
Pageof 35